project id: TCGA-CESC; case submitter id: TCGA-ZJ-AAX4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.78; rna integrity number: 7.1; age at index: 85; days to birth: -31258; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1923; age at diagnosis: 31258; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 21.0; figo stage: Stage II; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: Not Reported; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 0.03123287671232876; pack years smoked: 0.57; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-ZJ-AAX4-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 24.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;